Literature DB >> 21365264

Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.

Muhammad R Sohail1, Salwa Hussain, Katherine Y Le, Chadi Dib, Christine M Lohse, Paul A Friedman, David L Hayes, Daniel Z Uslan, Walter R Wilson, James M Steckelberg, Larry M Baddour.   

Abstract

AIMS: The infection rates of implantable cardioverter-defibrillators systems (ICDs) are higher than that of permanent pacemaker. Risk factors associated with ICD infection have not been characterized and are the subject of the current investigation.
METHODS: All patients who had an ICD implanted at Mayo Clinic Rochester between 1991 and 2008 were retrospectively reviewed. Each case of ICD infection was matched with two non-infected controls. Cases of ICD infection were further stratified by early- (≤ 6 months) versus late-onset (>6 months) infection. Multivariable analysis was performed to identify significant risk factors for ICD infection.
RESULTS: Sixty-eight patients with ICD infection and 136 matched controls met the inclusion criteria. Thirty-five cases presented with early-onset infection and 33 had late-onset device infection. Staphylococcal species were the most common pathogens in both groups of patients. Patients with early-onset infection were more likely to present with generator pocket infection (p = 0.02). Patients with multiple comorbid conditions (high Charlson index) tended to have longer hospital stay during implantation admission (p = 0.009). In a multivariable logistic regression model, the presence of epicardial leads (odds ratio (OR) = 9.7, p = 0.03) and postoperative complications at the generator pocket (OR = 27.2, p < 0.001) were significant risk factors for early-onset ICD infection, whereas longer duration of hospitalization at the time of implantation (2 days versus 1 day: OR = 33.1, p < 0.001; ≥ 3 days versus 1 day: OR = 49.0, p < 0.001) and chronic obstructive pulmonary disease (OR = 9.8, p = 0.02) were associated with late-onset infections.
CONCLUSIONS: Our study findings suggest that risk factors associated with early- and late-onset ICD infection are different. While circumstances that may increase the chances of pocket contamination in the perioperative period are more likely to be associated with early-onset ICD infection, overall poor health of the host may increase the likelihood of late-onset ICD infection. These factors should be considered when developing strategies to minimize risk of device infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365264     DOI: 10.1007/s10840-010-9537-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  28 in total

1.  Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.

Authors:  C Jan Willem Borleffs; Joep Thijssen; Mihály K de Bie; Johannes B van Rees; Guido H van Welsenes; Lieselot van Erven; Jeroen J Bax; Suzanne C Cannegieter; Martin J Schalij
Journal:  Pacing Clin Electrophysiol       Date:  2010-04-27       Impact factor: 1.976

2.  Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003.

Authors:  Andrew Voigt; Alaa Shalaby; Samir Saba
Journal:  J Am Coll Cardiol       Date:  2006-07-12       Impact factor: 24.094

3.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.

Authors:  Andrew E Epstein; John P Dimarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Heart Rhythm       Date:  2008-05-21       Impact factor: 6.343

Review 4.  Contemporary management of cardiovascular implantable electronic device infections.

Authors:  Muhammad R Sohail; Omer W Sultan; Sania S Raza
Journal:  Expert Rev Anti Infect Ther       Date:  2010-07       Impact factor: 5.091

5.  The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.

Authors:  Sana M Al-Khatib; F Lee Lucas; James G Jollis; David J Malenka; David E Wennberg
Journal:  J Am Coll Cardiol       Date:  2005-09-23       Impact factor: 24.094

6.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah Stoner; Larry M Baddour
Journal:  J Am Coll Cardiol       Date:  2007-04-23       Impact factor: 24.094

7.  Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery.

Authors:  Heather Bloom; Brian Heeke; Angel Leon; Fernando Mera; David Delurgio; John Beshai; Jonathan Langberg
Journal:  Pacing Clin Electrophysiol       Date:  2006-02       Impact factor: 1.976

8.  Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah M Jenkins; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2008-01       Impact factor: 7.616

9.  Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years.

Authors:  H J Trappe; P Pfitzner; H Klein; P Wenzlaff
Journal:  Br Heart J       Date:  1995-01

10.  Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial.

Authors:  Jose M Tolosana; Paola Berne; Lluis Mont; Magda Heras; Antonio Berruezo; Joan Monteagudo; David Tamborero; Begoña Benito; Josep Brugada
Journal:  Eur Heart J       Date:  2009-05-31       Impact factor: 29.983

View more
  18 in total

1.  Management of Cardiac Electronic Device Infections: Challenges and Outcomes.

Authors:  Rikke Esberg Kirkfeldt; Jens Brock Johansen; Jens Cosedis Nielsen
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

2.  Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).

Authors:  Mohit K Turagam; Darbhamulla V Nagarajan; Krzysztof Bartus; Akash Makkar; Vijay Swarup
Journal:  J Interv Card Electrophysiol       Date:  2017-04-17       Impact factor: 1.900

3.  New Insights into Predictors of Cardiac Implantable Electronic Device Infection.

Authors:  Hossein Sadeghi; Abolfath Alizadehdiz; Amirfarjam Fazelifar; Zahra Emkanjoo; Majid Haghjoo
Journal:  Tex Heart Inst J       Date:  2018-06-01

4.  Implantable cardioverter defibrillator lead-related methicillin resistant Staphylococcus aureus endocarditis: Importance of heightened awareness.

Authors:  Obiora F Anusionwu; Cheri Smith; Alan Cheng
Journal:  World J Cardiol       Date:  2012-07-26

5.  Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.

Authors:  Matthew J Kolek; Neel J Patel; Walter K Clair; S Patrick Whalen; Jeffrey N Rottman; Arvindh Kanagasundram; Sharon T Shen; Pablo J Saavedra; Juan C Estrada; Robert L Abraham; Christopher R Ellis
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-06

6.  Early Aspergillus pacemaker pocket infection: Case and review.

Authors:  Jennifer L Pincus; Maximillian Jahng; Larry Massie; Samuel A Lee
Journal:  Med Mycol Case Rep       Date:  2012-05-24

7.  Sonication of explanted cardiac implants improves microbial detection in cardiac device infections.

Authors:  Alessandra Oliva; Bich Lien Nguyen; Maria T Mascellino; Alessandra D'Abramo; Marco Iannetta; Antonio Ciccaglioni; Vincenzo Vullo; Claudio M Mastroianni
Journal:  J Clin Microbiol       Date:  2012-11-28       Impact factor: 5.948

8.  Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.

Authors:  Hui-Chen Han; Nathaniel M Hawkins; Charles M Pearman; David H Birnie; Andrew D Krahn
Journal:  Europace       Date:  2021-06-23       Impact factor: 5.214

9.  Impact of Pacemaker Lead Characteristics on Pacemaker Related Infection and Heart Perforation: A Nationwide Population-Based Cohort Study.

Authors:  Yu-Sheng Lin; Tien-Hsing Chen; Sheng-Ping Hung; Dong Yi Chen; Chun-Tai Mao; Ming-Lung Tsai; Shih-Tai Chang; Chun-Chieh Wang; Ming-Shien Wen; Mien-Cheng Chen
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

10.  Fistula Formation 6 Years after Removal of Infected Pacemaker Leads.

Authors:  Thomas Schroeter; Philipp Kiefer; Matthias Sauer; Friedrich Wilhelm Mohr
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.